Google DeepMind has introduced AlphaGenome 2, an AI model that enhances understanding of how DNA mutations impact various cell types. This model builds on its predecessor by offering a more detailed analysis of genetic variants, trained on over 100 million cell profiles across 68 tissues.
The new model can predict effects on individual cells without needing retraining and identifies more genetic variants than before. It aims to connect genetic data to cellular biology, potentially aiding in disease treatment development by providing insights into specific cell types and states.